Impact of hemolysis on multiomic pancreatic cancer biomarker discovery: De-risking precision medicine biomarker development

被引：0
|
作者：
Kiebish, Michael A. [1 ]
Shah, Punit [1 ]
Bussberg, Valerie [1 ]
Tolstikov, Vladimir [1 ]
Searfoss, Rick [1 ]
Ofori-Mensa, Kennedy [1 ]
Grund, Eric M. [1 ]
Darkwah, Abena [1 ]
Chen, Emily Y. [1 ]
Greenwood, Bennett [1 ]
Ntoso, Ellaine Adu [1 ]
Rodrigues, Leonardo [1 ]
Liu, Mia [1 ]
Granger, Elder [1 ]
Bountra, Chas [2 ]
Sarangarajan, Rangaprasad [1 ]
Moser, A. J. [3 ]
Narain, Niven R. [1 ]
机构：
[1] BERG LLC, Framingham, MA USA
[2] Univ Oxford, Oxford, England
[3] Harvard Med Sch, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-2860
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2860
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The importance of altruism to biomarker development for pancreatic cancer.
    Heo, Danny H. J.
    DeCicco, Corinne
    Singer, Tori
    Vemulapalli, Vijetha
    Yee, Christopher
    Kiebish, Michael A.
    Grund, Eric M.
    Akmaev, Viatcheslav R.
    Narain, Niven R.
    Kennedy, Kevin F.
    Moser, A. James
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [42] Biomarker Landscape in Multicenter China Lung Cancer Precision Medicine Registry
    Wu, J.
    Ji, W.
    Fu, N.
    Rong, H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S426 - S427
  • [43] Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response
    Seppala, Toni T.
    Zimmerman, Jacquelyn W.
    Suri, Reecha
    Zlomke, Haley
    Ivey, Gabriel D.
    Szabolcs, Annamaria
    Shubert, Christopher R.
    Cameron, John L.
    Burns, William R.
    Lafaro, Kelly J.
    He, Jin
    Wolfgang, Christopher L.
    Zou, Ying S.
    Zheng, Lei
    Tuveson, David A.
    Eshlemann, James R.
    Ryan, David P.
    Kimmelman, Alec C.
    Hong, Theodore S.
    Ting, David T.
    Jaffee, Elizabeth M.
    Burkhart, Richard A.
    CLINICAL CANCER RESEARCH, 2022, 28 (15) : 3296 - 3307
  • [44] Computer-aided biomarker discovery for precision medicine: data resources, models and applications
    Lin, Yuxin
    Qian, Fuliang
    Shen, Li
    Chen, Feifei
    Chen, Jiajia
    Shen, Bairong
    BRIEFINGS IN BIOINFORMATICS, 2019, 20 (03) : 952 - 975
  • [45] Exploitation of Nanoparticle-Blood Interaction for Biomarker Discovery in Pancreatic Cancer
    Caputo, Damiano D.
    Cascone, Chiara
    Pozzi, Daniela
    Digiacomo, Luca
    Palchetti, Sara
    Caracciolo, Giulio
    Coppola, Roberto
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (04) : S133 - S133
  • [46] Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer
    Du, Yan
    Yao, Kai
    Feng, Qingbo
    Mao, Feiyu
    Xin, Zechang
    Xu, Peng
    Yao, Jie
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [47] A functional genomic approach to biomarker discovery for the early detection of pancreatic cancer
    Killary, Ann
    Frazier, Marsha
    Sen, Subrata
    CANCER BIOMARKERS, 2008, 4 (03) : 147 - 148
  • [48] Project Survival®: High-fidelity longitudinal phenotypic and multiomic characterization of pancreatic ductal adenocarcinoma (PDAC) for biomarker discovery
    Moser, A. J.
    Kiebish, M. A.
    Grund, E. M.
    DeCicco, C. L.
    Chand, N. M.
    Schawkat, K.
    Perez-Melara, G. L.
    Miller, G. M.
    Rodrigues, L. O.
    Granger, E.
    Sarangarajan, R.
    Narain, N. R.
    ANNALS OF ONCOLOGY, 2020, 31 : S947 - S948
  • [49] AI-driven biomarker discovery: enhancing precision in cancer diagnosis and prognosis
    Alum, Esther Ugo
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [50] Applications of artificial intelligence (AI) in ovarian cancer, pancreatic cancer, and image biomarker discovery
    Mikdadi, Dina
    O'Connell, Kyle A.
    Meacham, Philip J.
    Dugan, Madeleine A.
    Ojiere, Michael O.
    Carlson, Thaddeus B.
    Klenk, Juergen A.
    CANCER BIOMARKERS, 2022, 33 (02) : 173 - 184
12345